Ningbo David Medical Device Co Ltd (300314) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ningbo David Medical Device Co Ltd (300314) has a cash flow conversion efficiency ratio of 0.120x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥146.39 Million ≈ $21.42 Million USD) by net assets (CN¥1.22 Billion ≈ $178.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300314 net asset quality index to measure how much of total assets are equity-financed.
Ningbo David Medical Device Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Ningbo David Medical Device Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Ningbo David Medical Device Co Ltd (300314) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Ningbo David Medical Device Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ningbo David Medical Device Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
IGG Inc
F:I91
|
-0.006x |
|
Grape King Bio Ltd
TW:1707
|
0.097x |
|
Norma Group AG NA O.N.
XETRA:NOEJ
|
0.035x |
|
National Research Corp
NASDAQ:NRC
|
0.532x |
|
Camping World Holdings Inc
NYSE:CWH
|
0.290x |
|
Zaptec AS
OL:ZAP
|
0.579x |
|
Dare Technology Co Ltd
SHE:000910
|
0.003x |
|
Beijing Hezong Science&Technology Co Ltd
SHE:300477
|
0.068x |
Annual Cash Flow Conversion Efficiency for Ningbo David Medical Device Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Ningbo David Medical Device Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Ningbo David Medical Device Co Ltd (300314) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.23 Billion ≈ $180.42 Million |
CN¥89.25 Million ≈ $13.06 Million |
0.072x | -9.91% |
| 2024-12-31 | CN¥1.17 Billion ≈ $170.96 Million |
CN¥93.87 Million ≈ $13.74 Million |
0.080x | -30.86% |
| 2023-12-31 | CN¥1.16 Billion ≈ $170.25 Million |
CN¥135.20 Million ≈ $19.78 Million |
0.116x | +10.33% |
| 2022-12-31 | CN¥1.06 Billion ≈ $155.01 Million |
CN¥111.57 Million ≈ $16.33 Million |
0.105x | +102.65% |
| 2021-12-31 | CN¥990.53 Million ≈ $144.95 Million |
CN¥51.48 Million ≈ $7.53 Million |
0.052x | -64.02% |
| 2020-12-31 | CN¥953.52 Million ≈ $139.53 Million |
CN¥137.73 Million ≈ $20.15 Million |
0.144x | +35.17% |
| 2019-12-31 | CN¥828.85 Million ≈ $121.29 Million |
CN¥88.57 Million ≈ $12.96 Million |
0.107x | +21.09% |
| 2018-12-31 | CN¥792.71 Million ≈ $116.00 Million |
CN¥69.95 Million ≈ $10.24 Million |
0.088x | +25.47% |
| 2017-12-31 | CN¥778.30 Million ≈ $113.89 Million |
CN¥54.74 Million ≈ $8.01 Million |
0.070x | -31.58% |
| 2016-12-31 | CN¥748.55 Million ≈ $109.54 Million |
CN¥76.95 Million ≈ $11.26 Million |
0.103x | +48.20% |
| 2015-12-31 | CN¥697.90 Million ≈ $102.12 Million |
CN¥48.41 Million ≈ $7.08 Million |
0.069x | -31.55% |
| 2014-12-31 | CN¥668.97 Million ≈ $97.89 Million |
CN¥67.79 Million ≈ $9.92 Million |
0.101x | +12.68% |
| 2013-12-31 | CN¥628.16 Million ≈ $91.92 Million |
CN¥56.49 Million ≈ $8.27 Million |
0.090x | -43.67% |
| 2012-12-31 | CN¥592.09 Million ≈ $86.64 Million |
CN¥94.53 Million ≈ $13.83 Million |
0.160x | -60.87% |
| 2011-12-31 | CN¥164.25 Million ≈ $24.03 Million |
CN¥67.02 Million ≈ $9.81 Million |
0.408x | -20.74% |
| 2010-12-31 | CN¥110.28 Million ≈ $16.14 Million |
CN¥56.78 Million ≈ $8.31 Million |
0.515x | -0.62% |
| 2009-12-31 | CN¥79.57 Million ≈ $11.64 Million |
CN¥41.22 Million ≈ $6.03 Million |
0.518x | +253.06% |
| 2008-12-31 | CN¥82.46 Million ≈ $12.07 Million |
CN¥12.10 Million ≈ $1.77 Million |
0.147x | -- |
About Ningbo David Medical Device Co Ltd
Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and sales of pediatric childcare equipment, surgical instruments and other products worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It offers infusion pumps, transcutaneous jaundice detector… Read more